| Mitochondrial dysfunction in the hypertensive rat brain: respiratory complexes exhibit assembly defects in hypertension. | |
| | |
MedLine Citation:
|
PMID: 18172056 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The central nervous system plays a critical role in the normal control of arterial blood pressure and in its elevation in virtually all forms of hypertension. Mitochondrial dysfunction has been increasingly associated with the development of hypertension. Therefore, we examined whether mitochondrial dysfunction occurs in the brain in hypertension and characterized it at the molecular scale. Mitochondria from whole brain and brain stem from 12-week-old spontaneously hypertensive rats with elevated blood pressure (190+/-5 mm Hg) were compared against those from age-matched normotensive (134+/-7 mm Hg) Wistar Kyoto rats (n=4 in each group). Global differential analysis using 2D electrophoresis followed by tandem mass spectrometry-based protein identification suggested a downregulation of enzymes involved in cellular energetics in hypertension. Targeted differential analysis of mitochondrial respiratory complexes using the classical blue-native SDS-PAGE/Western method and a complementary combination of sucrose-gradient ultracentrifugation/tandem mass spectrometry revealed previously unknown assembly defects in complexes I, III, IV, and V in hypertension. Interestingly, targeted examination of the brain stem, a regulator of cardiovascular homeostasis and systemic blood pressure, further showed the occurrence of mitochondrial complex I dysfunction, elevated reactive oxygen species production, decreased ATP synthesis, and impaired respiration in hypertension. Our findings suggest that in already-hypertensive spontaneously hypertensive rats, the brain respiratory complexes exhibit previously unknown assembly defects. These defects impair the function of the mitochondrial respiratory chain. This mitochondrial dysfunction localizes to the brain stem and is, therefore, likely to contribute to the development, as well as to pathophysiological complications, of hypertension. |
| | |
Authors:
|
Ana Lopez-Campistrous; Li Hao; Wang Xiang; Dong Ton; Paul Semchuk; Joerg Sander; Michael J Ellison; Carlos Fernandez-Patron |
Related Documents
:
|
17852096 - Proportion of isolated clinical hypertension in primary care settings. comparison of ta... 9308606 - Hormonal and humeral considerations in hypertensive disease. 3487196 - The influence of socioeconomic factors on blood pressure control during a community-bas... 16533126 - Hypertension: trends in prevalence, incidence, and control. 1171446 - Determination of glomerular intracapillary and transcapillary pressure gradients from s... 22825796 - Pressure dependent aerosol formation from the cyclohexene gas-phase ozonolysis in the p... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-01-02 |
Journal Detail:
|
Title: Hypertension Volume: 51 ISSN: 1524-4563 ISO Abbreviation: Hypertension Publication Date: 2008 Feb |
Date Detail:
|
Created Date: 2008-01-24 Completed Date: 2008-02-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7906255 Medline TA: Hypertension Country: United States |
Other Details:
|
Languages: eng Pagination: 412-9 Citation Subset: IM |
Affiliation:
|
Department of Biochemistry, Institute for Biomolecular Design, University of Alberta, Edmonton, Alberta, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Brain / enzymology* Cardiovascular System / physiopathology Doxycycline / pharmacology Electrophoresis, Gel, Two-Dimensional Enzyme Inhibitors / pharmacology Homeostasis Hypertension / complications*, enzymology, physiopathology* Metalloendopeptidases / antagonists & inhibitors Mitochondrial Diseases / enzymology, etiology* Multienzyme Complexes / drug effects, genetics* Protein Processing, Post-Translational* / drug effects Proteomics Rats Rats, Inbred SHR Rats, Inbred WKY Tandem Mass Spectrometry |
| Chemical | |
Reg. No./Substance:
|
0/Enzyme Inhibitors; 0/Multienzyme Complexes; 564-25-0/Doxycycline; EC 3.4.24.-/Metalloendopeptidases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin tre...
Next Document: Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor.